Navigation Links
NCPA Statement on Florida Study About Prescription Drug Prices in Underserved Areas
Date:11/5/2008

ALEXANDRIA, Va., Nov. 5 /PRNewswire-USNewswire/ -- Health Service Online has published a study called "Variation in Drug Prices at Pharmacies: Are Drug Prices Higher in Poor Areas," by Walid F. Gellad. In response, Bruce T. Roberts, RPh, National Community Pharmacists Association (NCPA) executive vice president and CEO, issued the following statement.

"The study by Dr. Walid Gellad is helpful in raising awareness about the variation in prescription drug prices between wealthier and poorer neighborhoods in Florida, but unfortunately misses the mark in many ways. For example, more than 90 percent of prescription drug prices are set by large pharmacy benefit managers (PBMs) with no ability for community pharmacies to negotiate, so these small businesses literally can't influence what their patients pay. In addition, underserved and rural communities often have a higher percentage of Medicaid and Medicare patients, making the number of cash prescriptions minimal. On a related note, using 'U&C' (usual and customary) as the data point for measuring cash pricing in the study is antiquated. In reality, U&C was an appropriate indicator decades ago when the majority of prescriptions were paid by cash; however that's now the exception rather than the rule."

"However, the study highlights one very important concern--the lack of access to a community pharmacy in rural and underserved areas. Large drugstore chains sometimes avoid these areas due to profitability concerns, often leaving pharmacy small business owners as the last hope for fulfilling the medications needs in these areas. Unfortunately, take-it-or-leave-it PBM contracts in Florida have resulted in no retail pharmacy presence in 74 ZIP codes where the median income is under $30,000, representing slightly over 185,000 people. This dynamic needs to be remedied."

"The best solution for helping those living in underserved neighborhoods is to allow community pharmacy owners to have good fait
'/>"/>

SOURCE National Community Pharmacists Association
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. Statement of Eli Lilly and Company on Dr. David Egilman Settlement:
2. Takeda statement on ACTOS meta-analysis published in the Journal of the American Medical Association
3. Takeda Statement on ACTOS(R) (Pioglitazone HCl) Meta-Analysis Published in the Journal of the American Medical Association
4. Statement by Mike Leavitt Secretary of Health and Human Services on the United States-China Bilateral Meetings on Food and Drug Safety
5. Statement by Oscar S. Wyatt, Jr.
6. Statement from Employment Policies Institute on Senator Hillary Clintons Health Care Plan
7. Pelosi Statement on Proposed Entitlement Task Force
8. Statement by Robert Greenstein, Executive Director of the Center on Budget and Policy Priorities, on the New Congressional SCHIP Agreement
9. Statement on House/Senate Agreement on SCHIP Legislation
10. Statement from the Alliance for Quality Nursing Home Care
11. Produce for Better Health Foundation Releases Statement on Study Saying Fruit & Vegetable Consumption Not Strongly Associated With Colon Cancer Risk

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/26/2009)...vid Kim of the Live Life Again Center, a practice ...f a growing number of physicians who are taking a...nect with individuals who are interested in surgic...Dr. Kim is utilizing Facebook to share before-and-...th the community. , Dalla...
(Date:11/26/2009)... Communications announces a highly effective and u... struggling to make an economic recovery. , ...u fears is the type of challenge that could send a...ng to Dr. David Benton, business growth expert and...em – The Rfactor Intensive . “Fear ...
(Date:11/25/2009)...swire-USNewswire/--WhenmostpeopleheartheacronymTMJ...vepatientsthehelptheyneed.TMJstandsfortheTemporal-...cts/connectswithyourskull(temporalbone). ,, The...ainwithchewing,clickingorpoppingofthejaw.Butmanyot...headaches,fatigue,sleepdisturbances,irritability,a...
(Date:11/25/2009).../PRNewswire-FirstCall/-- OnyxPharmaceuticals,Inc....ttwoinvestoreventsinDecember: ,, ASHBriefing ...,, Principalinvestigatorswilldiscussdatapresent...torymultiplemyeloma,asfeaturedatthe51stAmericanSoc...ewOrleans,LA.Theteleconferencewillbeginat9:00a.m.C...
(Date:11/25/2009)...e/-SentinelleMedicalInc.,aleadingmanufacturerofbre...sasuiteofnewleadingedgeclinicalapplicationsonitsAe...adiologicalSocietyofNorthAmerica(RSNA)annualmeetin...pplicationsleveragetheuniquehighqualityimagesgener...portmultipleimagingmodalitiesformulti-parametricas...
Breaking Medicine News(10 mins):Health News:Dallas Texas Weight Loss Surgeon Using Social Media To Reach Out to Patients 2Health News:Dallas Texas Weight Loss Surgeon Using Social Media To Reach Out to Patients 3Health News:Pharmacist Injects Cure for Ailing Businesses 2Health News:Onyx Pharmaceuticals Announces December 2009 Investor Events 2Health News:Sentinelle Medical Launches Aegis Suite of Oncology 4D Visualization Software with PureWeb(TM) Technology 2Health News:Sentinelle Medical Launches Aegis Suite of Oncology 4D Visualization Software with PureWeb(TM) Technology 3
...athologists at The University of Texas Health Scie...modified protein that may help people with a hard-... as Hemophilia A. The discovery and the results of...III), people with Hemophilia A typically receive i...
...nterim results from a nationwide clinical trial le... researcher suggest that radiofrequency ablation i...ith Barretts esophagus, a condition that can lead ...placebo or sham treatment, said Dr. Nicholas Shahe...
...s money and time spent in intensive care units, re...y News) -- Endotracheal tubes coated with silver d...t bacteria, researchers report. , Patients on ven...ed pneumonia. , "Ventilator-associated pneumonia c...
... State University selected as winner, COLUMBUS, O...o 13 colleges and universities across the State of...will be added as registered organ and,tissue donor...ssue and eye,recovery agencies, partnered with the...
...NGTON HEIGHTS, Ill., May 19 Plastic,surgeons perf...ures in 2007,-- ranging from repairing dog bite wo...nstructing breasts following mastectomy., (Photo:...lives?, On average, members of The American Socie...
...rder triggered by gluten in common foods, such as ...DAY, May 19 (HealthDay News) -- New research could...c disease, according to studies presented at the D... small intestine triggered by a protein called glu...
Other Medicine News:Health News:Blood-clotting protein modified for people with hard-to-treat hemophilia 2Health News:Radiofrequency ablation is effective treatment for dysplasia in Barrett's esophagus 2Health News:Silver-Coated Endotracheal Tubes Cut Down on Infections 2Health News:Silver-Coated Endotracheal Tubes Cut Down on Infections 3Health News:Do It Now College Program Registers Nearly 125,000 New Organ and Tissue Donors 2Health News:Do It Now College Program Registers Nearly 125,000 New Organ and Tissue Donors 3Health News:Each Day, Plastic Surgeons Are Reconstructing Lives: Restoring Function, Improving Appearances, and Elevating Self-Esteem 2Health News:Advances Aid Treatment, Diagnosis of Celiac Disease 2Health News:Advances Aid Treatment, Diagnosis of Celiac Disease 3
(Date:11/25/2009)...ov.25/PRNewswire-FirstCall/--HeskaCorporation(HSKA...andspecialtyproductstotheveterinaryindustry,announ...orthesupplyofbloodgasproductsandaffiliatedconsumab....newscom.com/cgi-bin/prnh/20000622/HESKALOGO ) ,...nthefieldofadvancedpoint-of-carediagnostics,"comme...
(Date:11/25/2009)....25/PRNewswire-FirstCall/--ERT(Nasdaq: ERES ),anno...sidentandCEO,andKeithSchneck,theCompany,sExecutive...AnnualPiperJaffrayHealthCareConferenceat1:30PMESTo...stedpartiesmayaccessthepresentationbyvisitingtheCo...ebcastmayalsobeaccessedat http://www.corporate-ir....
(Date:11/25/2009)...,Nov.25/PRNewswire/--TheFDAgrantedtraditionalappro...eosidereversetranscriptaseinhibitor(NNRTI).INTELEN...ment-experiencedadultswhoareexperiencingvirologicf...tiretroviral(ARV)agents.Thetraditionalapprovalisba...ndDUET-2.INTELENCEiscurrentlymarketedintheU.S.byTi...
Breaking Medicine Technology:Heska Announces Supply Agreement With Roche Diagnostics 2Heska Announces Supply Agreement With Roche Diagnostics 3ERT to Present at the 21st Annual Piper Jaffray Health Care Conference on December 1, 2009 2U.S. Food And Drug Administration (FDA) Grants Traditional Approval for INTELENCE(R) (etravirine) 2U.S. Food And Drug Administration (FDA) Grants Traditional Approval for INTELENCE(R) (etravirine) 3U.S. Food And Drug Administration (FDA) Grants Traditional Approval for INTELENCE(R) (etravirine) 4Wayne County Community College Districts Downtown Campus Presents the 2nd Annual Summer Safety Fair 50053 1Wayne County Community College Districts Downtown Campus Presents the 2nd Annual Summer Safety Fair 50053 2The Canned Food Alliance Answers the Call for Back To Basics With Essential Kitchen Toolkit 50049 1The Canned Food Alliance Answers the Call for Back To Basics With Essential Kitchen Toolkit 50049 2The Canned Food Alliance Answers the Call for Back To Basics With Essential Kitchen Toolkit 50049 3The Canned Food Alliance Answers the Call for Back To Basics With Essential Kitchen Toolkit 50049 4The Canned Food Alliance Answers the Call for Back To Basics With Essential Kitchen Toolkit 50049 5Beyonce 26 Solange Knowles to Perform Benefit Concert in Minneapolis on July 16 50044 1
...ial demonstrate safety and,efficacy of first FDA-a... with moderate to severe COPD --, NAPA, Calif., Ma...t two clinical data presentations will be given at...acic Society (ATS) on,Sunday, May 20, at the Mosco... detail Phase III clinical data demonstrating the,...
...SS WIRE)--May 17, 2007 - Results,published this we...,vaccine, GARDASIL (Quadrivalent Human Papillomavi... 100 percent effective in,preventing high-grade vu... and 18, two types strongly associated with these ...in women who were not,infected with HPV types targ...
Other Medicine Technology:Clinical Trial Data for Perforomist Inhalation Solution to be,Presented at ATS on May 20, 2007 2Clinical Trial Data for Perforomist Inhalation Solution to be,Presented at ATS on May 20, 2007 3Clinical Trial Data for Perforomist Inhalation Solution to be,Presented at ATS on May 20, 2007 4Data Published in The Lancet Show Gardasil was 100 Percent,Effective in Preventing High-Grade Vulvar and Vaginal Lesions,Caused by HPV Types 16 and 18 2Data Published in The Lancet Show Gardasil was 100 Percent,Effective in Preventing High-Grade Vulvar and Vaginal Lesions,Caused by HPV Types 16 and 18 3Data Published in The Lancet Show Gardasil was 100 Percent,Effective in Preventing High-Grade Vulvar and Vaginal Lesions,Caused by HPV Types 16 and 18 4Data Published in The Lancet Show Gardasil was 100 Percent,Effective in Preventing High-Grade Vulvar and Vaginal Lesions,Caused by HPV Types 16 and 18 5Data Published in The Lancet Show Gardasil was 100 Percent,Effective in Preventing High-Grade Vulvar and Vaginal Lesions,Caused by HPV Types 16 and 18 6Data Published in The Lancet Show Gardasil was 100 Percent,Effective in Preventing High-Grade Vulvar and Vaginal Lesions,Caused by HPV Types 16 and 18 7Data Published in The Lancet Show Gardasil was 100 Percent,Effective in Preventing High-Grade Vulvar and Vaginal Lesions,Caused by HPV Types 16 and 18 8Data Published in The Lancet Show Gardasil was 100 Percent,Effective in Preventing High-Grade Vulvar and Vaginal Lesions,Caused by HPV Types 16 and 18 9Data Published in The Lancet Show Gardasil was 100 Percent,Effective in Preventing High-Grade Vulvar and Vaginal Lesions,Caused by HPV Types 16 and 18 10Data Published in The Lancet Show Gardasil was 100 Percent,Effective in Preventing High-Grade Vulvar and Vaginal Lesions,Caused by HPV Types 16 and 18 11Data Published in The Lancet Show Gardasil was 100 Percent,Effective in Preventing High-Grade Vulvar and Vaginal Lesions,Caused by HPV Types 16 and 18 12Data Published in The Lancet Show Gardasil was 100 Percent,Effective in Preventing High-Grade Vulvar and Vaginal Lesions,Caused by HPV Types 16 and 18 13Data Published in The Lancet Show Gardasil was 100 Percent,Effective in Preventing High-Grade Vulvar and Vaginal Lesions,Caused by HPV Types 16 and 18 14Data Published in The Lancet Show Gardasil was 100 Percent,Effective in Preventing High-Grade Vulvar and Vaginal Lesions,Caused by HPV Types 16 and 18 15Data Published in The Lancet Show Gardasil was 100 Percent,Effective in Preventing High-Grade Vulvar and Vaginal Lesions,Caused by HPV Types 16 and 18 16Data Published in The Lancet Show Gardasil was 100 Percent,Effective in Preventing High-Grade Vulvar and Vaginal Lesions,Caused by HPV Types 16 and 18 17Data Published in The Lancet Show Gardasil was 100 Percent,Effective in Preventing High-Grade Vulvar and Vaginal Lesions,Caused by HPV Types 16 and 18 18Data Published in The Lancet Show Gardasil was 100 Percent,Effective in Preventing High-Grade Vulvar and Vaginal Lesions,Caused by HPV Types 16 and 18 19Data Published in The Lancet Show Gardasil was 100 Percent,Effective in Preventing High-Grade Vulvar and Vaginal Lesions,Caused by HPV Types 16 and 18 20Data Published in The Lancet Show Gardasil was 100 Percent,Effective in Preventing High-Grade Vulvar and Vaginal Lesions,Caused by HPV Types 16 and 18 21Data Published in The Lancet Show Gardasil was 100 Percent,Effective in Preventing High-Grade Vulvar and Vaginal Lesions,Caused by HPV Types 16 and 18 22Data Published in The Lancet Show Gardasil was 100 Percent,Effective in Preventing High-Grade Vulvar and Vaginal Lesions,Caused by HPV Types 16 and 18 23Data Published in The Lancet Show Gardasil was 100 Percent,Effective in Preventing High-Grade Vulvar and Vaginal Lesions,Caused by HPV Types 16 and 18 24Data Published in The Lancet Show Gardasil was 100 Percent,Effective in Preventing High-Grade Vulvar and Vaginal Lesions,Caused by HPV Types 16 and 18 25Data Published in The Lancet Show Gardasil was 100 Percent,Effective in Preventing High-Grade Vulvar and Vaginal Lesions,Caused by HPV Types 16 and 18 26Data Published in The Lancet Show Gardasil was 100 Percent,Effective in Preventing High-Grade Vulvar and Vaginal Lesions,Caused by HPV Types 16 and 18 27Data Published in The Lancet Show Gardasil was 100 Percent,Effective in Preventing High-Grade Vulvar and Vaginal Lesions,Caused by HPV Types 16 and 18 28Data Published in The Lancet Show Gardasil was 100 Percent,Effective in Preventing High-Grade Vulvar and Vaginal Lesions,Caused by HPV Types 16 and 18 29Data Published in The Lancet Show Gardasil was 100 Percent,Effective in Preventing High-Grade Vulvar and Vaginal Lesions,Caused by HPV Types 16 and 18 30Data Published in The Lancet Show Gardasil was 100 Percent,Effective in Preventing High-Grade Vulvar and Vaginal Lesions,Caused by HPV Types 16 and 18 31Data Published in The Lancet Show Gardasil was 100 Percent,Effective in Preventing High-Grade Vulvar and Vaginal Lesions,Caused by HPV Types 16 and 18 32
Spirobac Filter
... helps provide protection to the exposed airway of...ly lightweight making it ideal for active young ch... and moisture recovery, it ensures patient comfort...filters have ISO standard tapered ends to assure a...
circuitGuard™ HME
Clear-Therm Mini™ + Micro Mount with Flextube
Medicine Products: